
GC25863
Riamilovir
Also known as 7-methylsulfanyl-3-nitro-6H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-one
Riamilovir (Triazavirin) is a broad-spectrum antiviral drug candidate, which can be used for potential application against the Coronavirus 2019-nCoV
ChemicalCAS123606-06-4MW228.19FormulaC5H4N6O3S
- CAS number
- 123606-06-4
- Molecular weight
- 228.19
- Formula
- C5H4N6O3S
- Solubility
- DMSO: 46 mg/mL (201·59 mM);Water: 46 mg/mL (201·59 mM);Ethanol: Insoluble
- InChIKey
- IDVQGNMSSHPZSJ-UHFFFAOYSA-N
- Catalogue number
- GC25863
- Brand
- GLPBIO
Computed properties PubChem CID 3113817 · XLogP 0.4 · TPSA 141 Ų · H-bond donors 1
- XLogP
- 0.4
- TPSA
- 141 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 1
- Heavy atoms
- 15
SMILES CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-]
Computed descriptors from PubChem (CID 3113817), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il